Barclays’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.81M Sell
51,948
-10,607
-17% -$696K ﹤0.01% 2158
2025
Q4
$3.84M Sell
62,555
-1,819
-3% -$117K ﹤0.01% 2432
2025
Q3
$4.7M Sell
64,374
-4,973
-7% -$392K ﹤0.01% 2251
2025
Q2
$5.16M Buy
69,347
+670
+1% +$46.8K ﹤0.01% 2099
2025
Q1
$5.15M Buy
68,677
+12,508
+22% +$1.16M ﹤0.01% 1888
2024
Q4
$5.74M Buy
56,169
+10,940
+24% +$1.25M ﹤0.01% 2024
2024
Q3
$4.77M Buy
45,229
+10,966
+32% +$1.12M ﹤0.01% 2132
2024
Q2
$3.19M Sell
34,263
-3,097
-8% -$328K ﹤0.01% 1821
2024
Q1
$4.87M Buy
37,360
+10,811
+41% +$1.27M ﹤0.01% 1876
2023
Q4
$3.01M Buy
26,549
+14,809
+126% +$1.28M ﹤0.01% 2559
2023
Q3
$964K Sell
11,740
-558
-5% -$49K ﹤0.01% 2362
2023
Q2
$1.15M Sell
12,298
-7,081
-37% -$566K ﹤0.01% 2214
2023
Q1
$1.32M Sell
19,379
-1,985
-9% -$161K ﹤0.01% 2523
2022
Q4
$1.52M Sell
21,364
-2,683
-11% -$183K ﹤0.01% 2455
2022
Q3
$1.49M Buy
24,047
+16,575
+222% +$1.19M ﹤0.01% 1941
2022
Q2
$499K Buy
7,472
+5,976
+399% +$449K ﹤0.01% 2855
2022
Q1
$108K Sell
1,496
-9,687
-87% -$793K ﹤0.01% 3740
2021
Q4
$1.07M Buy
11,183
+3,172
+40% +$215K ﹤0.01% 2787
2021
Q3
$392K Buy
8,011
+6,015
+301% +$302K ﹤0.01% 3306
2021
Q2
$100K Sell
1,996
-8,610
-81% -$424K ﹤0.01% 3842
2021
Q1
$416K Buy
+10,606
New +$412K ﹤0.01% 3284
2020
Q3
Sell
-3,500
Closed -$30K 5235
2020
Q2
$30K Buy
3,500
+319
+10% +$1.97K ﹤0.01% 5105
2020
Q1
$16K Sell
3,181
-5,945
-65% -$66.8K ﹤0.01% 5702
2019
Q4
$129K Buy
9,126
+4,569
+100% +$93.7K ﹤0.01% 5329
2019
Q3
$148K Sell
4,557
-1,435
-24% -$36.2K ﹤0.01% 5174
2019
Q2
$119K Sell
5,992
-3,571
-37% -$81.5K ﹤0.01% 5556
2019
Q1
$255K Sell
9,563
-10,766
-53% -$306K ﹤0.01% 4645
2018
Q4
$502K Buy
20,329
+13,922
+217% +$341K ﹤0.01% 3818
2018
Q3
$202K Buy
6,407
+3,353
+110% +$121K ﹤0.01% 4988
2018
Q2
$114K Sell
3,054
-8,342
-73% -$326K ﹤0.01% 5148
2018
Q1
$371K Buy
+11,396
New +$212K ﹤0.01% 4257
2014
Q4
Sell
-914
Closed -$9K 7284
2014
Q3
$9K Sell
914
-1,070
-54% -$13.5K ﹤0.01% 6931
2014
Q2
$20K Buy
1,984
+823
+71% +$10.7K ﹤0.01% 6503
2014
Q1
$11K Buy
1,161
+97
+9% +$1.52K ﹤0.01% 6872
2013
Q4
$11K Buy
1,064
+79
+8% +$1.41K ﹤0.01% 6967
2013
Q3
$10K Sell
985
-180
-15% -$3.41K ﹤0.01% 6783
2013
Q2
$25K Buy
+1,165
New +$29.5K ﹤0.01% 6716

Other funds holding BXC

Barclays's BXC Position: Q1 2026 in Review

Barclays reduced its BlueLinx (BXC) stake by 17% in Q1 2026, selling an estimated $696K and leaving 51,948 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2158.

Barclays first reported a position in BXC in Q2 2013 and has held it in 37 quarters since. The position peaked at $5.74M in Q4 2024. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.

  • Barclays held 51,948 shares of BlueLinx worth $2.81M as of Q1 2026.
  • Barclays sold 10,607 BlueLinx shares in Q1 2026, an estimated $696K.
  • BlueLinx made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2158 holding.
  • Barclays first reported a position in BlueLinx in Q2 2013 and has held it in 37 quarters since.
  • Barclays's BlueLinx position peaked at $5.74M in Q4 2024.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.